ScreenerHero

ALZAlzinova AB

STO · SE · Healthcare · Biotechnology · alzinova.com
0.8190SEK0.00%Mkt Cap: 15.87M $P/E: —

Alzinova AB (publ), a clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer's disease in Sweden. The company's lead product candidate is the ALZ-101, a therapeutic vaccine for the treatment o…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap15.87M $
Enterprise Value12.03M $
Revenue (TTM)2.45M $
Gross Profit2.54M $
Net Income (TTM)-2.51M $
Revenue/Share0.0238 USD
Last Price0.8190 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.35
PEG—
EV/EBITDA—
EV/Revenue4.90
P/S6.41
P/B0.85
EPS (TTM)-0.20
EPS (Forward)-0.60
52W Range
0.386023% of range2.280
52W High2.280 SEK
52W Low0.3860 SEK
Profitability
Gross Margin100.00%
Oper. Margin-99.01%
EBITDA Margin0.00%
Profit Margin-103.58%
ROE-21.54%
ROA-18.31%
Growth
Revenue Growth-18.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.25M $
CapEx (TTM)2.54M $
FCF Margin-157.32%
FCF Yield-24.32%
Net Debt-1.01M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.01
Current Ratio1.37
Quick Ratio1.33
Book Value/Sh0.9600 SEK
Cash/Share0.0730 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.900 SEK
Upside (mean)+132.0%
Target Range1.700 SEK – 2.100 SEK
SEK1.700+132.0% to meanSEK2.100
# Analysts2
Ownership
Shares Out.202.64M
Float129.62M
Insiders24.93%
Institutions14.04%
Technical
SMA 500.7687 (+6.5%)
SMA 2000.8000 (+2.4%)
Beta1.11
S&P 52W Chg18.16%
Avg Vol (30d)6.81M
Avg Vol (10d)1.45M
Technical Indicators
RSI (14)45.9
MACD0.0322
MACD Signal0.0706
MACD Hist.-0.0384
BB Upper1.207 SEK
BB Middle0.9583 SEK
BB Lower0.7094 SEK
BB Width51.95%
ATR (14)0.1272 SEK
Vol Ratio (20d)0.67x